These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14592523)

  • 1. Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.
    Meltzer PC; McPhee M; Madras BK
    Bioorg Med Chem Lett; 2003 Nov; 13(22):4133-7. PubMed ID: 14592523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacology of site specific cocaine abuse treatment agents: 8-substituted isotropane (3-azabicyclo[3.2.1]octane) dopamine uptake inhibitors.
    Kim DI; Schweri MM; Deutsch HM
    J Med Chem; 2003 Apr; 46(8):1456-64. PubMed ID: 12672245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3-disubstituted 6-azabicyclo[3.2.1]octanes as novel dopamine transporter inhibitors.
    Quirante J; Vila X; Bonjoch J; Kozikowski AP; Johnson KM
    Bioorg Med Chem; 2004 Mar; 12(6):1383-91. PubMed ID: 15018911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further structure-activity relationship studies on 8-substituted-3-[2-(diarylmethoxyethylidenyl)]-8-azabicyclo[3.2.1]octane derivatives at monoamine transporters.
    Cararas SA; Izenwasser S; Wade D; Housman A; Verma A; Lomenzo SA; Trudell ML
    Bioorg Med Chem; 2011 Dec; 19(24):7551-8. PubMed ID: 22055716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and dopamine transporter binding affinities of 3alpha-benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes.
    Bradley AL; Izenwasser S; Wade D; Klein-Stevens C; Zhu N; Trudell ML
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2387-90. PubMed ID: 12161139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Carbomethoxy-3-aryl-8-bicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters.
    Meltzer PC; Blundell P; Yong YF; Chen Z; George C; Gonzalez MD; Madras BK
    J Med Chem; 2000 Aug; 43(16):2982-91. PubMed ID: 10956207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Nagase H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2689-92. PubMed ID: 22445285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists.
    Crombie AL; Antrilli TM; Campbell BA; Crandall DL; Failli AA; He Y; Kern JC; Moore WJ; Nogle LM; Trybulski EJ
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3742-5. PubMed ID: 20471258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of dopamine transporter selective 3-diarylmethoxymethyl-8-arylalkyl-8-azabicyclo[3.2.1]octane derivatives.
    Zhang S; Izenwasser S; Wade D; Xu L; Trudell ML
    Bioorg Med Chem; 2006 Dec; 14(23):7943-52. PubMed ID: 16905323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-substituted-6-amino-5-phenylbicyclo[2.2.2]octanes.
    Javanmard S; Deutsch HM; Collard DM; Kuhar MJ; Schweri MM
    J Med Chem; 1999 Nov; 42(23):4836-43. PubMed ID: 10579846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new n-substituted cyclic imides with expected anxiolytic activity. XXI. Derivatives of 1-acetyldibenzo-[e.h]-bicyclo[2.2.2]-octane-2,3-dicarboximide.
    Kossakowski J; Szczepek W; Pakosińska-Parys M
    Acta Pol Pharm; 2002; 59(6):418-23. PubMed ID: 12669762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of dopamine transporter selective 3-[2-(diarylmethoxyethylidene)]-8-alkylaryl-8-azabicyclo[3.2.1]octanes.
    Bradley AL; Izenwasser S; Wade D; Cararas S; Trudell ML
    Bioorg Med Chem Lett; 2003 Feb; 13(4):629-32. PubMed ID: 12639545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicyclo[3.2.1]octanes: synthesis and inhibition of binding at the dopamine and serotonin transporters.
    Meltzer PC; Blundell P; Chen Z; Yong YF; Madras BK
    Bioorg Med Chem Lett; 1999 Mar; 9(6):857-62. PubMed ID: 10206550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 6- and 7- hydroxy-8-azabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters.
    Meltzer PC; Wang B; Chen Z; Blundell P; Jayaraman M; Gonzalez MD; George C; Madras BK
    J Med Chem; 2001 Aug; 44(16):2619-35. PubMed ID: 11472216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.
    Zou MF; Cao J; Kopajtic T; Desai RI; Katz JL; Newman AH
    J Med Chem; 2006 Oct; 49(21):6391-9. PubMed ID: 17034144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of derivatives of 2,4-bis(arylmethino)-8-butyl-8- azabicyclo[3.2.1]octan-3-one].
    Gutkowska B; Baranowski A; Herold F
    Acta Pol Pharm; 1989; 46(3):212-8. PubMed ID: 2618767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of bicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes.
    Cho TP; Gang LZ; Long YF; Yang W; Qian W; Lei Z; Jing LJ; Ying F; Ke YP; Ying L; Jun F
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3521-5. PubMed ID: 20488704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
    Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
    J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
    Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
    J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Aryl-2-carbomethoxybicyclo[3.2.1]oct-2-enes inhibit WIN 35,428 binding potently and selectively at the dopamine transporter.
    Meltzer PC; Blundell P; Huang H; Liu S; Yong YF; Madras BK
    Bioorg Med Chem; 2000 Mar; 8(3):581-90. PubMed ID: 10732975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.